Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Research Frontiers (REFR) Liabilities and Shareholders Equity (2016 - 2025)

Research Frontiers' Liabilities and Shareholders Equity history spans 10 years, with the latest figure at $2.3 million for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity changed N/A year-over-year to $2.3 million; the TTM value through Dec 2025 reached $12.0 million, changed N/A, while the annual FY2025 figure was $2.3 million, N/A changed from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $2.3 million at Research Frontiers, down from $2.8 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $6.0 million in Q3 2022 and bottomed at $2.3 million in Q4 2025.
  • The 5-year median for Liabilities and Shareholders Equity is $3.9 million (2022), against an average of $4.2 million.
  • The largest annual shift saw Liabilities and Shareholders Equity plummeted 40.76% in 2022 before it soared 55.43% in 2023.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $4.5 million in 2021, then rose by 18.05% to $5.4 million in 2022, then dropped by 28.25% to $3.9 million in 2023, then dropped by 22.11% to $3.0 million in 2024, then dropped by 24.92% to $2.3 million in 2025.
  • Per Business Quant, the three most recent readings for REFR's Liabilities and Shareholders Equity are $2.3 million (Q4 2025), $2.8 million (Q3 2025), and $3.2 million (Q2 2025).